At present, no standardized pathologic evaluation criteria of soft tissue sarcomas (STS) exist.

Also, it is unclear whether the cut-off for prognostic relevance is similar among STS subtypes.

Here, the EORTC–STBSG proposes a standardization of the pathological examination process.

This manuscript focuses on reporting of STS resection specimens after neoadjuvant therapy.